HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased serum level of IL-7 in patients with active Graves' disease.

AbstractBACKGROUND:
Graves' disease (GD) is a common autoimmune disease which is one of the major causes of hyperthyroidism. Interleukin 7 (IL-7) has been recently reported to play an important role in various autoimmune diseases, but its role in the pathogenesis of GD has not been assessed. The aim of this study was to evaluate the levels of IL-7 and the soluble form of its receptor (sIL-7R) in the serum of GD patients, and to identify their association with disease activity.
METHODS:
A total of 37 GD patients were enrolled into the experimental group and 16 individuals into the control group. All patients were further classified into three subgroups: a GD-active group (hyperthyroidism and TRAb (thyroid stimulating hormone receptor antibody) >7.5 U/L) (N=15), a GD-inactive group (euthyreosis and TRAb<1 U/L) (N=8), and other GD patients (euthyreosis and TRAb>1 U/L) (N=14). Concentrations of IL-7 and sIL-7R were assayed with ELISA. Additionally, the relationship between IL-7 and sIL-7R serum concentrations with disease activity (free triiodothyronine [FT3], free thyroxine [FT4], thyroid stimulating hormone [TSH] and TRAb) was also analyzed.
RESULTS:
The serum concentrations of IL-7 in GD-active patients were significantly lower than those of the control group as well as the GD-inactive and GD-other groups. The serum level of IL-7 in GD patients negatively correlated with FT4 and TRAb concentrations. Moreover, no significant difference was observed in the serum level of sIL-7R in GD patients compared to the control group.
CONCLUSIONS:
These observations suggest that IL-7 may play a role in the pathogenesis of GD and may be associated with its clinical activity. To this end, the serum level of IL-7 could be an additional diagnostic biomarker predictive of the disease and could be particularly valuable for TRAb-negative GD patients.
AuthorsEwelina Motylewska, Martyna Nieć, Agnieszka Siejka, Jan Komorowski, Hanna Ławnicka, Jacek Świętosławski, Henryk Stępień
JournalCytokine (Cytokine) Vol. 75 Issue 2 Pg. 373-9 (Oct 2015) ISSN: 1096-0023 [Electronic] England
PMID26113403 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Ltd. All rights reserved.
Chemical References
  • Autoantibodies
  • Biomarkers
  • IL7 protein, human
  • Interleukin-7
  • Receptors, Interleukin-7
  • Receptors, Thyrotropin
  • Triiodothyronine
  • Thyrotropin
  • Thyroxine
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Autoantibodies (blood)
  • Biomarkers (blood)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Graves Disease (blood, diagnosis)
  • Humans
  • Hyperthyroidism (blood)
  • Interleukin-7 (blood)
  • Male
  • Middle Aged
  • Receptors, Interleukin-7 (blood)
  • Receptors, Thyrotropin (immunology)
  • Thyroid Gland (metabolism)
  • Thyrotropin (blood)
  • Thyroxine (blood)
  • Triiodothyronine (blood)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: